Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to 0.34.

  • Maravai Lifesciences Holdings' Debt Ratio fell 1551.6% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year decrease of 1551.6%. This contributed to the annual value of 0.29 for FY2024, which is 1670.56% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Debt Ratio stood at 0.34, which was down 1551.6% from 0.33 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Debt Ratio registered a high of 0.41 during Q3 2024, and its lowest value of 0.23 during Q4 2022.
  • Moreover, its 5-year median value for Debt Ratio was 0.34 (2022), whereas its average is 0.33.
  • In the last 5 years, Maravai Lifesciences Holdings' Debt Ratio tumbled by 4075.94% in 2022 and then soared by 7630.06% in 2024.
  • Maravai Lifesciences Holdings' Debt Ratio (Quarter) stood at 0.39 in 2021, then crashed by 40.76% to 0.23 in 2022, then surged by 52.48% to 0.35 in 2023, then fell by 16.71% to 0.29 in 2024, then increased by 17.48% to 0.34 in 2025.
  • Its Debt Ratio stands at 0.34 for Q3 2025, versus 0.33 for Q2 2025 and 0.31 for Q1 2025.